{
  "schema_version": "pdp_json_v1",
  "peptide": {
    "canonical_name": "Thymosin Alpha-1",
    "short_name": "Thymosin Alpha-1",
    "aliases": [
      "thymalfasin",
      "ta1"
    ],
    "classification": {
      "category": "approved_human",
      "needs_prescription": true,
      "notes": "Classification describes what Thymosin Alpha-1 is and the general domain where it appears."
    },
    "status": {
      "category": "approved_human",
      "jurisdiction": "GLOBAL",
      "last_reviewed": "2026-01-18",
      "human_use_note": "This entry summarizes how the compound is discussed/used in the real world without endorsing use or providing instructions."
    },
    "structure": {
      "sequence_oneletter": "",
      "amino_acid_seq": "",
      "molecular_formula": "",
      "molecular_weight": null,
      "structure_image_url": ""
    },
    "risk": {
      "current_score": 5,
      "severity": "moderate",
      "likelihood": "possible",
      "evidence_grade": "mechanistic_only",
      "developmental_risk": true,
      "unknowns_penalty": true,
      "rationale": "Risk rating is conservative and reflects known uncertainties, evidence limitations, and potential for non-obvious harms.",
      "risk_score": 5
    },
    "sections": {
      "overview": [
        {
          "claim_type": "overview",
          "title": "What it is",
          "population_group": "general",
          "confidence": "unknown",
          "evidence_grade": "mechanistic_only",
          "text": "What it is and why it is studied are summarized here in a conservative, evidence-bounded way.",
          "evidence_refs": [
            "E1",
            "E2",
            "E3"
          ]
        }
      ],
      "use_cases": [],
      "mechanism": [],
      "human_effects": [],
      "preclinical_effects": [],
      "hypothesized_effects": [],
      "time_dynamics": [],
      "risks": [],
      "contraindications": [],
      "monitoring": [],
      "observed_exposure_ranges": [
        {
          "route": "",
          "unit": "",
          "min": null,
          "max": null,
          "frequency": "",
          "duration": "",
          "population_group": "general",
          "notes": "Descriptive only. Observed in studies; not instructions.",
          "evidence_refs": []
        }
      ],
      "developmental_risk_block": [
        {
          "claim_type": "risk",
          "population_group": "adolescent",
          "confidence": "unknown",
          "evidence_grade": "mechanistic_only",
          "text": "Developmental risk is flagged due to limited adolescent data and uncertain long-term effects. Endocrine, growth, neurodevelopmental, and metabolic setpoints may be sensitive to perturbation. This section is descriptive only; uncertainty is explicitly acknowledged.",
          "evidence_refs": []
        }
      ],
      "interaction_summary": [],
      "current_outlook_bullets": [
        "studied are summarized here in a conservative, evidence-bounded way",
        "general recovery and resilience interest (anecdotal)",
        "common biohacker curiosity due to community reports",
        "interest in mechanisms suggested by early evidence",
        "used in goal-based stacking discussions (anecdotal)",
        "exploration in wellness communities despite evidence limits"
      ]
    },
    "evidence": [
      {
        "id": "E1",
        "source_id": "33362999",
        "source_type": "journal_article",
        "evidence_grade": "human_interventional",
        "title": "Thymosin alpha 1: A comprehensive review of the literature",
        "year": 2020,
        "url": "https://pubmed.ncbi.nlm.nih.gov/33362999/",
        "notes": "Clinical review context; not a protocol or dosing guide."
      },
      {
        "id": "E2",
        "source_id": "37110771",
        "source_type": "journal_article",
        "evidence_grade": "human_interventional",
        "title": "Thymosin α1 and Its Role in Viral Infectious Diseases",
        "year": 2023,
        "url": "https://pubmed.ncbi.nlm.nih.gov/37110771/",
        "notes": "Review of mechanisms + clinical contexts; not a protocol or dosing guide."
      },
      {
        "id": "E3",
        "source_id": "FDA-TA1-BULK-2024",
        "source_type": "regulatory",
        "evidence_grade": "mechanistic_only",
        "title": "FDA document referencing Thymosin alpha-1 bulk drug substances (regulatory context)",
        "year": 2024,
        "url": "https://www.fda.gov/media/183892/download",
        "notes": "Regulatory/compounding context; not clinical efficacy proof."
      }
    ],
    "changelog": [
      {
        "date": "2026-01-18",
        "change_type": "initial_entry",
        "summary": "Initial canonical entry for Thymosin Alpha-1",
        "detail": "Generated from queue ingestion (Phase 6). Requires human-authored, evidence-bounded content.",
        "evidence_refs": []
      },
      {
        "date": "2026-01-18T19:45:38+00:00",
        "change_type": "content_update",
        "summary": "Added conservative evidence refs for TA1 identity/approval context (no instructions).",
        "detail": "Linked overview to regulatory/clinical/mechanistic references without adding protocols or dosing guidance.",
        "evidence_refs": [
          "E1",
          "E2",
          "E3"
        ]
      },
      {
        "date": "2026-01-18T19:58:03+00:00",
        "change_type": "content_update",
        "summary": "Replaced placeholder evidence entries with specific sources (no instructions).",
        "detail": "Filled TA1 evidence metadata for E1–E3 with specific identifiers/links. No dosing/protocol content added.",
        "evidence_refs": [
          "E1",
          "E2",
          "E3"
        ]
      }
    ],
    "meta": {},
    "topics": {
      "primary": [
        "topic_immune_modulation"
      ]
    },
    "slug": "thymosin-alpha-1"
  },
  "canonical_name": "Thymosin Alpha-1",
  "interactions": {
    "drug_classes": [
      "corticosteroids",
      "immunosuppressants"
    ],
    "supplement_classes": [],
    "peptides": []
  }
}
